Form D · Other Real Estate
NexPoint Life Sciences DST
Dallas, TX · CIK 0001901493
Offering snapshot reported Jun 6, 2022 · SEC filing
- Reported sold
- $105M Offering amount: $108M
- Investors reported
- 236 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 16, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$104,460,836 → $104,959,651
- Reported investors234 → 236
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 6, 2022 | Amendment | $104,959,651 | $498,815vs May 24, 2022 | 236 | SEC filing |
| May 24, 2022 | Amendment | $104,460,836 | $150,000vs May 10, 2022 | 234 | SEC filing |
| May 10, 2022 | Amendment | $104,310,836 | $2,120,727vs Apr 26, 2022 | 233 | SEC filing |
| Apr 26, 2022 | Amendment | $102,190,109 | $4,352,569vs Apr 19, 2022 | 227 | SEC filing |
| Apr 19, 2022 | Amendment | $97,837,540 | $8,843,906vs Apr 5, 2022 | 218 | SEC filing |
| Apr 5, 2022 | Amendment | $88,993,634 | $7,183,290vs Mar 22, 2022 | 196 | SEC filing |
| Mar 22, 2022 | Amendment | $81,810,344 | $13,878,126vs Mar 8, 2022 | 175 | SEC filing |
| Mar 8, 2022 | Amendment | $67,932,218 | $28,035,962vs Feb 23, 2022 | 145 | SEC filing |
| Feb 23, 2022 | Amendment | $39,896,256 | $4,895,136vs Feb 10, 2022 | 120 | SEC filing |
| Feb 10, 2022 | Amendment | $35,001,120 | $10,765,926vs Jan 26, 2022 | 100 | SEC filing |
| Jan 26, 2022 | Amendment | $24,235,194 | $11,478,154vs Jan 18, 2022 | 70 | SEC filing |
| Jan 18, 2022 | Amendment | $12,757,040 | $7,487,388vs Jan 4, 2022 | 36 | SEC filing |
| Jan 4, 2022 | Amendment | $5,269,652 | $70,000vs Dec 28, 2021 | 8 | SEC filing |
| Dec 28, 2021 | Initial | $5,199,652 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $9.3M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-426919
Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Emerson Equity LLC | 130032 | |
| Maxwell Financial Group, Inc. | 167863 | |
| TCFG Wealth Management, LLC | 164153 | |
| Great Point Capital LLC | 114203 | |
| Centaurus Financial, Inc. | 30833 | |
| Concorde Investment Services LLC | 151604 | |
| Stax Capital | 300607 | |
| Thornhill Securities, Inc. | 22333 | |
| Growth Capital Services, Inc. | 124658 | |
| Lightpath Capital, Inc. | 34617 | |
| McDermott Investment Services, LLC | 154926 | |
| Innovation Partners LLC | 146344 | |
| Capulent LLC | 155155 | |
| Metropolitan Capital Investment Banc, Inc. | 148820 | |
| American Trust Investment Services, Inc. | 3001 | |
| Patrick Capital Markets, LLC | 16518 | |
| Wilson-Davis & Co., Inc. | 3777 | |
| Network 1 Financial Securities Inc. | 13577 | |
| Kalos Capital, Inc. | 44337 | |
| Whitehall-Parker Securities, Inc. | 10608 | |
| FNEX Capital, LLC | 166316 | |
| Huntwicke Securities, LLC | 146993 | |
| Dempsey Lord Smith, LLC | 141238 | |
| Stonecrest Capital Markets, Inc. | 39616 |
Source: Form D, filed Jun 6, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Goetz | Executive |
| Matt Mc Graner | Executive |
| N/A Nex Point Real Estate Advisors Iv, L.P. | Executive |
| N/A Nrea Casper Investment Co, Llc | Executive |
| N/A Nrea Casper, Llc | Executive |
Issuer details
Industry: Other Real Estate (See others in industry)
Address:
300 Crescent Court Suite 700
Dallas, TX, 75201
Dallas, TX, 75201